landmark NIH hypertension study will change how patients with high blood pressure are treated

January 2003

New results from the landmark NIH hypertension study will change how patients with high blood pressure are treated.

Currently, most hypertension patients start on an ACE inhibitor, beta-blocker, or calcium channel blocker.

A thiazide diuretic is often added when extra blood pressure control is needed.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

landmark NIH hypertension study will change how patients with high blood pressure are treated
Strattera, the first NON-stimulant drug approved for ADHD
Provigil (modafinil), the latest prescription "lifestyle drug"
some patients are accidentally overdosing on their methotrexate
Cardiology You'll be hearing a lot about C-reactive protein
Cardiology statins decrease the effects of Plavix
Dermatology treatments for wrinkles
Dermatology Aldara (imiquimod cream) to treat actinic keratoses
Infectious Diseases Copegus, a new ribavirin tablet for hepatitis C
Infectious Diseases how to treat gonorrhea now that Wyeth is discontinuing cefixime (Suprax)
Women's Health how to treat women with epilepsy
Natural Medicines "seals of approval" on brand name dietary supplements
Osteoporosis Forteo (teriparatide), human parathyroid hormone for treating osteoporosis
Is it legal for patients to import prescription drugs
whether a "float test" tells if a metered-dose inhaler is empty